Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 21;23(3):1151.
doi: 10.3390/ijms23031151.

Production and Biochemical Characterization of Dimeric Recombinant Gremlin-1

Affiliations

Production and Biochemical Characterization of Dimeric Recombinant Gremlin-1

Stefania Mitola et al. Int J Mol Sci. .

Abstract

Gremlin-1 is a secreted cystine-knot protein that acts as an antagonist of bone morphogenetic proteins (BMPs), and as a ligand of heparin and the vascular endothelial growth factor receptor 2 (VEGFR2), thus regulating several physiological and pathological processes, including embryonic development, tissue fibrosis and cancer. Gremlin-1 exerts all these biological activities only in its homodimeric form. Here, we propose a multi-step approach for the expression and purification of homodimeric, fully active, histidine-tagged recombinant gremlin-1, using mammalian HEK293T cells. Ion metal affinity chromatography (IMAC) of crude supernatant followed by heparin-affinity chromatography enables obtaining a highly pure recombinant dimeric gremlin-1 protein, exhibiting both BMP antagonist and potent VEGFR2 agonist activities.

Keywords: HEK293T expression system; cystine-knot protein; dimer; gremlin-1.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Expression and IMAC purification of recombinant gremlin in HEK293T cells. (A) WB analysis of gremlin expression in the supernatant (SN) or the lysate (Ly) of HEK293T cells transiently transfected with pcDNA3-Gremlin-1-HisTag (gremlin) or empty vector (ctrl). (B) WB analysis of gremlin expression in the supernatant of HEK293T cells in the absence or the presence of 6 mM sodium butyrate. (C) WB analysis of gremlin expressed and secreted by HEK293T cells in the absence or the presence of PNGaseF glycosidase. (D) WB analysis of gremlin expressed and secreted by HEK293T cells 0–36 h post transfection. (EH) IMAC of recombinant gremlin expressed in the supernatant of HEK293T cells. The chromatogram is shown in (E). Fractions were analyzed by WB for gremlin presence (F), or by silver staining (G). Non-reducing SDS-PAGE followed by anti-gremlin WB of purified gremlin is shown in (H). (I) MALDI-TOF/TOF–MS spectrum of IMAC-purified recombinant gremlin. Arrows indicate the two species of gremlin that were detected. (J) Total yield of IMAC gremlin purification. Data for one representative experiment of at least 3 independent repeats are shown.
Figure 2
Figure 2
IMAC-purified gremlin retained full BMP-dependent activity and only mild VEGFR2 activation capacity. (A) WB analysis of phospho-SMAD1/5/8 levels in HepG2 cells stimulated with BMP4 in the presence or the absence of indicated doses of IMAC-purified gremlin. FAK, loading control. (B) WB analysis of phospho-VEGFR2 levels in HUVE cells stimulated with increasing doses of IMAC-purified gremlin. FAK, loading control. (C) HUVE cells sprouting assay in the absence or the presence of increasing doses of IMAC-purified gremlin. Data are expressed as mean ± SEM. *, p < 0.05 Student’s t test vs. untreated cells. Data from one representative experiment of at least 3 independent repeats are shown.
Figure 3
Figure 3
Heparin-affinity chromatography allows isolating pure dimeric recombinant gremlin. IMAC-purified gremlin was subjected to a second step of purification through heparin-affinity chromatography. (A) WB analysis under non-reducing and reducing conditions of fractions eluted from the heparin-affinity chromatography. (B) Total yield of gremlin purification through heparin-affinity chromatography. Data from one representative experiment of at least 3 independent repeats are shown.
Figure 4
Figure 4
Pure dimeric gremlin exhibits strong biological activity. (A) Activation of Hepcidin promoter in a luciferase reporter assay upon BMP4 stimulation (50 ng/mL). When indicated, BMPs were pre-incubated in the absence, or presence, of the indicated concentration (ng/mL) of IMAC-purified or dimeric heparin-sepharose (HepSep)-purified gremlin. (B) pVEGFR2 accumulation into the VPM of GM7373-VEGFR2 endothelial cells adherent to IMAC-purified or dimeric HepSep-purified gremlin (dishes were coated with 2 µg/mL of recombinant proteins). (C) Cell proliferation of HUVE cells stimulated with increasing doses (ng/mL) of IMAC- or HepSep-purified gremlin. Data are expressed as mean ± SEM of three independent experiments. *, p < 0.05 Student’s t test vs. BMP-treated cells. #, p < 0.05 Student’s t test vs. gremlin IMAC-treated cells.

Similar articles

Cited by

References

    1. Topol L., Modi W., Koochekpour S., Blair D. DRM/GREMLIN (CKTSF1B1) maps to human chromosome 15 and is highly expressed in adult and fetal brain. Cytogenet. Cell Genet. 2000;89:79–84. doi: 10.1159/000015568. - DOI - PubMed
    1. Topol L.Z., Bardot B., Zhang Q., Resau J., Huillard E., Marx M., Calothy G., Blair D.G. Biosynthesis, Post-translation Modification, and Functional Characterization of Drm/Gremlin. J. Biol. Chem. 2000;275:8785–8793. doi: 10.1074/jbc.275.12.8785. - DOI - PubMed
    1. Stabile H., Mitola S.M.F., Moroni E., Belleri M., Nicoli S., Coltrini D., Peri F., Pessi A., Orsatti L., Talamo F., et al. Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. Blood. 2007;109:1834–1840. doi: 10.1182/blood-2006-06-032276. - DOI - PubMed
    1. Avsian-Kretchmer O., Hsueh A.J.W. Comparative Genomic Analysis of the Eight-Membered Ring Cystine Knot-Containing Bone Morphogenetic Protein Antagonists. Mol. Endocrinol. 2004;18:1–12. doi: 10.1210/me.2003-0227. - DOI - PubMed
    1. Kisonaite M., Wang X., Hyvönen M. Structure of Gremlin-1 and analysis of its interaction with BMP-2. Biochem. J. 2016;473:1593–1604. doi: 10.1042/BCJ20160254. - DOI - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources